|
TTD
Drug ID:
DAP001265
Drug
Information |
Name | Trimethadione | Synonyms | Abbott Brand of Trimethadione; Trimethdione; Trimetadione [DCIT]; SPBio_002390; D00392; Petilep; Trimethadione [INN:JAN]; Tridilona; BPBio1_000517; Tioxanona; Tridione (TN); InChI=1/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3; CHEBI:131804; Epidione; T0781_SIGMA; NSC 15799; C6H9NO3; 3,5,5-Trimethyl-1,3-oxazolidine-2,4-dione; Convexina; Pitmal; Tridone; AC1L1KNK; Minoaleuiatin; Trioxanona; NSC15799; NCGC00016383-01; Prestwick1_000515; 3,5,5-TRIMETHYL-OXAZOLIDINE-2,4-DIONE; CHEMBL695; Trimethinum; Trimetin; Trimethin; Prestwick2_000515; ZINC01530710; EINECS 204-845-8; Trimedal; Absentol; IRYJRGCIQBGHIV-UHFFFAOYSA-; Epidone; Convenixa; 3,5,5-Trojmetylooksazolidyno-2,4-dion [Polish]; Triozanona; UNII-R7GV3H6FQ4; Prestwick_815; trimethadione; Epixal; AC1Q3XZF; D014293; Trimethadion; Absetil; BRN 0121627; SMR000499583; Prestwick0_000515; Trimethadione (JP15/INN); Edion; Trimedone; HMS1569H11; Mino-Aleviatin; Tromedone; Petidon; T0781_FLUKA; Trimetadione; Neo-Absentol; CID5576; Prestwick3_000515; CAS-127-48-0; Tredione; Minoaleviatin; Trimetadiona; 3,5,5-Trimethyl-2,4-oxazolidinedione; WLN: T5OVNV EHJ C1 E1 E1; HMS2093D10; 3,5,5,-Trimethyloxazolidine-2,4-dione; Trimethadionum [INN-Latin]; MolPort-001-846-840; BSPBio_000469; A 2297; Troxidone; 127-48-0; Trimethadionum; 3,5,5-Trojmetylooksazolidyno-2,4-dion; Tridion; Trioksal; Tridione; NCGC00016383-02; LS-7736; MLS001076685; Etydion; Ptimal; Trilidona; 3,3,5-Trimethyl-2,4-diketooxazolidine; 2,4-OXAZOLIDINEDIONE, 3,5,5-TRIMETHYL-; Trimetadiona [INN-Spanish]; Petimalin; DB00347; Tricione; Petidion; NSC169503 | Indication | Epileptic conditions | Approved [1] | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format | Therapeutic Class | Anticonvulsants | CAS Number | CAS 127-48-0 | Formular | C6H9NO3 | PubChem Compound ID | CID 5576. | PubChem Substance ID | SID 79578. | SuperDrug ATC ID | N03AC02; | SuperDrug CAS ID | 000127480; | Target | Voltage-dependent T-type calcium channel |  | Blocker | [2] | Ref 1 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 005856 To Reference | Ref 2 | Prophylactic and therapeutic functions of T-type calcium blockers against noise-induced hearing loss. Hear Res. 2007 Apr;226(1-2):52-60. Epub 2006 Dec 31. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|
|